The DEEP project has received research funding from the European Union under the 7th Framework Programme
DEEP has created its own official Google+ and Facebook page!
By exploiting these very useful two-way communication forms of media, all project activities and results can be shared more quickly with a wide public audience while anyone interested in the project has the opportunity to contact […]
Another step forward has been made toward the enrollment of new patients in the DEEP-2 study, a phase III multicentre, randomised, open label, non-inferiority active-controlled trial aiming at comparing for the first time the efficacy of deferiprone (DFP) vs deferasirox (DFX) in paediatric patients affected […]
The Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) has recently launched the multicenter observational transversal study “Quality evaluation of the informative booklets for patients involved in the DEEP-2 trial” (QuBo). The overall aim of this study is to investigate the quality of the informative material addressed to […]
The most important achievements and activities carried out by the project have been collected and included in the DEEP Scientific Report related to the period from 01/01/2014 to 30/06/2015 which has been submitted to the European Commission on September 2015.
The report provided a […]
